MetaCap

Seres Therapeutics (MCRB) News

NASDAQ: MCRBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.24-0.09 (-6.77%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MCRB news summary

We found 2 recent headlines mentioning Seres Therapeutics (MCRB): 0 in the past week and 1 in the past 30 days, most often from GlobeNewswire. MCRB is making an outsized move today, down 6.77% at $1.24, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Seres Therapeutics Reports Third Quarter 2026 Financial Results and Announces Plans for Advancing Development of SER-155 To Prevent Immune Checkpoint Inhibitor-Related Enterocolitis (irEC)", was published by GlobeNewswire on Nov 4, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Seres Therapeutics headlines

Compare MCRB